Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Arthur Lederer, Ph.D.

Co-Author

This page shows the publications co-authored by James Lederer and Jennifer Brown.
Connection Strength

0.489
  1. Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia. Br J Haematol. 2022 Feb 15.
    View in: PubMed
    Score: 0.247
  2. A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia. Leukemia. 2022 03; 36(3):723-732.
    View in: PubMed
    Score: 0.242
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.